Theranostics,
Journal Year:
2022,
Volume and Issue:
12(5), P. 2483 - 2501
Published: Jan. 1, 2022
Rationale:
Forkhead/winged
helix
transcriptional
factor
P3
(FoxP3)
is
a
well-studied
transcription
that
maintains
the
activity
of
T
cells,
but
whether
cardiomyocytic
FoxP3
participates
in
cardiac
remodeling
(CR)
remains
unclear.The
present
study
was
to
investigate
role
CR
from
perspective
mitophagy.Methods:
induced
by
angiotensin
II
(AngII)
vitro,
or
isoproterenol
(Iso)
vivo
using
male
C57
mice
DTR
mice.Histological
changes
were
observed
hematoxylin-eosin
and
Masson
staining.Molecular
detected
immunohistochemistry,
immunofluorescence,
immunoblotting,
real-time
PCR.Mitophagy
shaped
transmission
electron
microscopy
co-localization.The
mRNA
expression
operated
siRNA
adeno
associated
virus
(AAV).Molecular
interactions
co-localization,
immunoprecipitation
(IP),
chromatin
IP.Results:
The
nuclear
translocation
downregulated
CR,
while
they
upregulated
after
triptolide
(TP)
treatment.In
left
ventricle
(LV)
mice,
autophagy
activated
continuously
myocardium,
TP
significantly
attenuated
it.AngII
massive
mitophagy
characterized
activation
regulatory
protein
5
(Atg5)-dependent
autophagic
flux.Critically,
Parkin
identified
as
main
adaptor
mediated
myocardial
responsible
for
effect
TP.Moreover,
downregulation
inhibited
AngII-induced
mitophagy.We
found
increased
inhibition
treatment
reversed
completely
FoxP3-deficient
LVs.Mechanistically,
interacted
with
motif
located
downstream
activating
4
(ATF4)-binding
involved
promoter
hijacked
free
ATF4
decrease
CR.Conclusion:
Cardiomyocytic
could
negatively
regulate
Parkin-mediated
restoring
provided
cardioprotective
strategy
inhibiting
excessive
mitophagy.
Journal of Medicinal Chemistry,
Journal Year:
2023,
Volume and Issue:
66(12), P. 7926 - 7942
Published: June 2, 2023
Alpha-synuclein
(αSyn)
species,
especially
the
oligomers
and
fibers,
are
associated
with
multiple
neurodegenerative
diseases
cannot
be
directly
targeted
under
conventional
pharmacological
paradigm.
Proteolysis-targeting
chimera
technology
confers
degradation
of
various
"undruggable"
targets;
however,
hardly
any
small-molecule
degrader
for
αSyn
aggregates
has
been
reported
yet.
Herein,
by
using
probe
molecule
sery308
as
a
warhead,
series
degraders
were
designed
synthesized.
Their
effects
on
evaluated
modified
pre-formed
fibril-seeding
cell
model.
Compound
2b
exhibited
highest
efficiency
(DC50
=
7.51
±
0.53
μM)
high
selectivity.
Mechanistic
exploration
revealed
that
both
proteasomal
lysosomal
pathways
involved
in
this
kind
degradation.
Moreover,
therapeutic
tested
SH-SY5Y
(human
neuroblastoma
line)
cells
Caenorhabditis
elegans.
Our
results
provided
new
class
candidates
against
synucleinopathies
broadened
substrate
spectrum
PROTAC-based
degraders.
British Journal of Pharmacology,
Journal Year:
2024,
Volume and Issue:
181(17), P. 3039 - 3063
Published: April 28, 2024
Abstract
Background
and
Purpose
Amyloid‐
β
(A
)
peptide
is
one
of
the
more
important
pathological
markers
in
Alzheimer's
disease
(AD).
The
development
AD
impairs
autophagy,
which
results
an
imbalanced
clearance
A
.
Our
previous
research
demonstrated
that
AdipoRon,
agonist
adiponectin
receptors,
decreased
deposition
enhanced
cognitive
function
AD.
However,
exact
mechanisms
by
AdipoRon
affects
remain
unclear.
Experimental
Approach
We
studied
how
autophagy
HT22
cells
APP/PS1
transgenic
mice.
also
investigated
signalling
pathway
involved
used
pharmacological
inhibitors
to
examine
role
this
process.
Key
Results
promotes
activating
neuronal
Interestingly,
we
found
induces
nuclear
translocation
GAPDH,
where
it
interacts
with
SIRT1/DBC1
complex.
This
interaction
then
leads
release
DBC1
activation
SIRT1,
turn
activates
autophagy.
Importantly,
inhibiting
either
GAPDH
or
SIRT1
suppress
activity
counteracts
elevated
caused
AdipoRon.
suggests
plays
a
critical
effect
on
autophagic
induction
Conclusion
Implications
enhancing
through
AdipoR1/AMPK‐dependent
subsequent
SIRT1.
novel
molecular
sheds
light
modulation
may
lead
new
therapeutic
strategies
targeting
pathway.
Brain Sciences,
Journal Year:
2022,
Volume and Issue:
12(5), P. 672 - 672
Published: May 21, 2022
Parkinson’s
disease
(PD)
is
a
chronic
progressive
neurodegenerative
that
increasingly
becoming
global
threat
to
the
health
and
life
of
elderly
worldwide.
Although
there
are
some
drugs
clinically
available
for
treating
PD,
these
treatments
can
only
alleviate
symptoms
PD
patients
but
cannot
completely
cure
disease.
Therefore,
exploring
other
potential
mechanisms
develop
more
effective
modify
course
still
highly
desirable.
Over
last
two
decades,
histone
deacetylases,
as
an
important
group
epigenetic
targets,
have
attracted
much
attention
in
drug
discovery.
This
review
focused
on
current
knowledge
about
deacetylases
involved
pathophysiology
their
inhibitors
used
studies.
Further
perspectives
related
small
molecules
inhibit
or
degrade
treat
were
also
discussed.
npj Parkinson s Disease,
Journal Year:
2022,
Volume and Issue:
8(1)
Published: Aug. 6, 2022
Abstract
The
abnormal
accumulation
of
α-synuclein
(α-syn)
is
a
crucial
factor
for
the
onset
and
pathogenesis
Parkinson’s
disease
(PD),
autophagy-lysosome
pathway
(ALP)
contributes
to
α-syn
turnover.
AMP-activated
protein
kinase
(AMPK)
mammalian
target
rapamycin
(mTOR)
regulate
autophagy
by
initiating
macroautophagy
cascade
promoting
lysosomal
biogenesis
via
increased
transcription
EB
(TFEB)
activity.
Hence,
activation
AMPK-mTOR-TFEB
axis-mediated
might
promote
clearance
in
PD.
Harmol
β-carboline
alkaloid
that
has
been
extensively
studied
variety
diseases
but
rarely
PD
models.
In
this
study,
we
aimed
evaluate
effect
underlying
mechanism
harmol
models
vitro
vivo.
We
show
reduces
ALP
dose-
time-dependent
manner
cell
model
overexpressed
human
A53T
mutant
α-syn.
also
demonstrate
promotes
translocation
TFEB
into
nucleus
accompanies
restoration
autophagic
flux
biogenesis.
Importantly,
improves
motor
impairment
down-regulates
levels
substantia
nigra
prefrontal
cortex
transgenic
mice
model.
Further
studies
revealed
activate
through
clearance.
These
vivo
improvements
activates
mediated
pathway,
resulting
reduced
α-syn,
suggesting
potential
benefit
treatment
Theranostics,
Journal Year:
2022,
Volume and Issue:
12(5), P. 2483 - 2501
Published: Jan. 1, 2022
Rationale:
Forkhead/winged
helix
transcriptional
factor
P3
(FoxP3)
is
a
well-studied
transcription
that
maintains
the
activity
of
T
cells,
but
whether
cardiomyocytic
FoxP3
participates
in
cardiac
remodeling
(CR)
remains
unclear.The
present
study
was
to
investigate
role
CR
from
perspective
mitophagy.Methods:
induced
by
angiotensin
II
(AngII)
vitro,
or
isoproterenol
(Iso)
vivo
using
male
C57
mice
DTR
mice.Histological
changes
were
observed
hematoxylin-eosin
and
Masson
staining.Molecular
detected
immunohistochemistry,
immunofluorescence,
immunoblotting,
real-time
PCR.Mitophagy
shaped
transmission
electron
microscopy
co-localization.The
mRNA
expression
operated
siRNA
adeno
associated
virus
(AAV).Molecular
interactions
co-localization,
immunoprecipitation
(IP),
chromatin
IP.Results:
The
nuclear
translocation
downregulated
CR,
while
they
upregulated
after
triptolide
(TP)
treatment.In
left
ventricle
(LV)
mice,
autophagy
activated
continuously
myocardium,
TP
significantly
attenuated
it.AngII
massive
mitophagy
characterized
activation
regulatory
protein
5
(Atg5)-dependent
autophagic
flux.Critically,
Parkin
identified
as
main
adaptor
mediated
myocardial
responsible
for
effect
TP.Moreover,
downregulation
inhibited
AngII-induced
mitophagy.We
found
increased
inhibition
treatment
reversed
completely
FoxP3-deficient
LVs.Mechanistically,
interacted
with
motif
located
downstream
activating
4
(ATF4)-binding
involved
promoter
hijacked
free
ATF4
decrease
CR.Conclusion:
Cardiomyocytic
could
negatively
regulate
Parkin-mediated
restoring
provided
cardioprotective
strategy
inhibiting
excessive
mitophagy.